Generating evidence to support the role of AI in diabetic eye screening: considerations from the UK National Screening Committee
Authors:
Open Access
- 6 April 2025
- journal article
- review article
- Published by Elsevier in The Lancet Digital Health
- Vol. 7 (5) , 100840
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Tackling algorithmic bias and promoting transparency in health datasets: the STANDING Together consensus recommendationsThe Lancet Digital Health, 2024
- A Datasheet for the INSIGHT Birmingham, Solihull, and Black Country Diabetic Retinopathy Screening DatasetOphthalmology Science, 2023
- Recommendations for the development and use of imaging test sets to investigate the test performance of artificial intelligence in health screeningThe Lancet Digital Health, 2022
- UK National Screening Committee's approach to reviewing evidence on artificial intelligence in breast cancer screeningThe Lancet Digital Health, 2022
- Validation and algorithmic audit of a deep learning system for the detection of proximal femoral fractures in patients in the emergency department: a diagnostic accuracy studyThe Lancet Digital Health, 2022
- The contribution of the English NHS Diabetic Eye Screening Programme to reductions in diabetes-related blindness, comparisons within Europe, and future challengesActa Diabetologica, 2021
- A global review of publicly available datasets for ophthalmological imaging: barriers to access, usability, and generalisabilityThe Lancet Digital Health, 2021
- GRADE guidelines: 22. The GRADE approach for tests and strategies—from test accuracy to patient-important outcomes and recommendationsJournal of Clinical Epidemiology, 2019
- Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysisThe Lancet Global Health, 2017
- Current methods of the U.S. Preventive Services Task ForceAmerican Journal of Preventive Medicine, 2001